These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 32233603)

  • 1. KLHL14, an ovarian and endometrial-specific gene, is over-expressed in ovarian and endometrial cancer.
    Han M; Yang HJ; Lin Q
    Math Biosci Eng; 2019 Dec; 17(2):1702-1717. PubMed ID: 32233603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A bioinformatics analysis of the clinicopathological and prognostic significance of
    Zheng HC; Ren DH; Zhang CY; Chen Y; Zhang L
    J Obstet Gynaecol; 2023 Dec; 43(1):2216280. PubMed ID: 37227120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kelch-like protein 14 promotes proliferation and migration of ovarian cancer cells.
    Chen Z; Wu M; Liu J
    Int J Clin Exp Pathol; 2020; 13(12):2950-2961. PubMed ID: 33425096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic values and prospective pathway signaling of MicroRNA-182 in ovarian cancer: a study based on gene expression omnibus (GEO) and bioinformatics analysis.
    Li Y; Li L
    J Ovarian Res; 2019 Nov; 12(1):106. PubMed ID: 31703725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stage IVB endometrial cancer: does applying an ovarian cancer treatment paradigm result in similar outcomes? A case-control analysis.
    Landrum LM; Moore KN; Myers TK; Lanneau GS; McMeekin DS; Walker JL; Gold MA
    Gynecol Oncol; 2009 Feb; 112(2):337-41. PubMed ID: 19041126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of significant genes with poor prognosis in ovarian cancer via bioinformatical analysis.
    Feng H; Gu ZY; Li Q; Liu QH; Yang XY; Zhang JJ
    J Ovarian Res; 2019 Apr; 12(1):35. PubMed ID: 31010415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of key biomarkers associated with development and prognosis in patients with ovarian carcinoma: evidence from bioinformatic analysis.
    Shen J; Yu S; Sun X; Yin M; Fei J; Zhou J
    J Ovarian Res; 2019 Nov; 12(1):110. PubMed ID: 31729978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The feasibility of detecting endometrial and ovarian cancer using DNA methylation biomarkers in cervical scrapings.
    Chang CC; Wang HC; Liao YP; Chen YC; Weng YC; Yu MH; Lai HC
    J Gynecol Oncol; 2018 Jan; 29(1):e17. PubMed ID: 29185275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of potential serum and urine-based microRNA as minimally-invasive biomarkers for breast and gynecological cancer.
    Ritter A; Hirschfeld M; Berner K; Jaeger M; Grundner-Culemann F; Schlosser P; Asberger J; Weiss D; Noethling C; Mayer S; Erbes T
    Cancer Biomark; 2020; 27(2):225-242. PubMed ID: 32083575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutually distinguishing microRNA signatures of breast, ovarian and endometrial cancers in vitro.
    Hirschfeld M; Ge I; Rücker G; Waldschmidt J; Mayer S; Jäger M; Voigt M; Kammerer B; Nöthling C; Berner K; Weiss D; Asberger J; Erbes T
    Mol Med Rep; 2020 Nov; 22(5):4048-4060. PubMed ID: 33000259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioinformatics Analysis of KIF1A Expression and Gene Regulation Network in Ovarian Carcinoma.
    Lu X; Li G; Liu S; Wang H; Zhang Z; Chen B
    Int J Gen Med; 2021; 14():3707-3717. PubMed ID: 34321916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of histological subtype in developing both ovarian and endometrial cancer: A longstanding nationwide incidence study.
    van Niekerk CC; van Dijck JAAM; Verbeek ALM
    Eur J Obstet Gynecol Reprod Biol; 2018 Feb; 221():17-22. PubMed ID: 29227847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and validation of IRF6 related to ovarian cancer and biological function and prognostic value.
    Hong S; Fu N; Sang S; Ma X; Sun F; Zhang X
    J Ovarian Res; 2024 Mar; 17(1):64. PubMed ID: 38493179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of Prognostic Biomarkers Among FAM83 Family Genes in Human Ovarian Cancer Through Bioinformatic Analysis and Experimental Verification.
    Lin S; Du J; Hao J; Luo X; Wu H; Zhang H; Zhao X; Xu L; Wang B
    Cancer Manag Res; 2021; 13():8611-8627. PubMed ID: 34815715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upregulation of the long non-coding RNA SPRY4-IT1 indicates a poor prognosis and promotes tumorigenesis in ovarian cancer.
    Li H; Liu C; Lu Z; Chen L; Wang J; Li Y; Ma H
    Biomed Pharmacother; 2017 Apr; 88():529-534. PubMed ID: 28129625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular Analysis of Prognosis and Immune Infiltration of Ovarian Cancer Based on Homeobox D Genes.
    Chen B; Gao C; Wang H; Sun J; Han Z
    Comput Math Methods Med; 2022; 2022():3268386. PubMed ID: 36213580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. KLHL14: A Novel Prognostic Biomarker and Therapeutic Target for Ovarian Cancer.
    Wang X; Sun R; Hong X; Chen C; Ding Y
    J Oncol; 2022; 2022():9799346. PubMed ID: 36046368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel risk score system for assessment of ovarian cancer based on co-expression network analysis and expression level of five lncRNAs.
    Zhao Q; Fan C
    BMC Med Genet; 2019 Jun; 20(1):103. PubMed ID: 31182053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased expression of ALDH5A1 predicts prognosis in patients with ovarian cancer.
    Tian X; Han Y; Yu L; Luo B; Hu Z; Li X; Yang Z; Wang X; Huang W; Wang H; Zhang Q; Ma D
    Cancer Biol Ther; 2017 Apr; 18(4):245-251. PubMed ID: 28346042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of perioperative red blood cell transfusion, anemia of cancer and global health status on the prognosis of elderly patients with endometrial and ovarian cancer.
    Anic K; Schmidt MW; Schmidt M; Krajnak S; Löwe A; Linz VC; Schwab R; Weikel W; Brenner W; Westphalen C; Rissel R; Hartmann EK; Conradi R; Hasenburg A; Battista MJ
    Front Oncol; 2022; 12():967421. PubMed ID: 36185177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.